Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Strategies towards a longer acting factor VIIIE L Saenko, S W PipeBlood|February 7, 2001
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIaS W Pipe, E L Saenko, A N Eickhorst, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The future of recombinant coagulation factorsE L Saenko, N M Ananyeva, M Shima, et al.Blood|December 24, 1998
Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivoS W Pipe, A N Eickhorst, S H McKinley, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2009
Functional roles of the factor VIII B domainS W PipeHaemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2006
The physician's role in selecting a factor replacement therapyS W PipeJournal of Thrombosis and Haemostasis : JTH|August 17, 2005
The promise and challenges of bioengineered recombinant clotting factorsS W PipeHaemophilia : the Official Journal of the World Federation of Hemophilia|June 8, 2018
Bioengineered molecules for the management of haemophilia: Promise and remaining challengesS W PipeThe Journal of Biological Chemistry|July 18, 1997
The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factorE L Saenko, D ScandellaThe Journal of Biological Chemistry|June 9, 1995
A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factorE L Saenko, D ScandellaPageof 9